Provided by Tiger Trade Technology Pte. Ltd.

Cyclerion Therapeutics, Inc.

3.89
-0.1800-4.42%
Post-market: 4.050.1600+4.11%19:57 EDT
Volume:65.75K
Turnover:263.10K
Market Cap:18.21M
PE:-2.24
High:4.29
Open:4.07
Low:3.78
Close:4.07
52wk High:8.48
52wk Low:1.03
Shares:4.68M
Float Shares:3.58M
Volume Ratio:2.12
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7328
EPS(LYR):-1.1100
ROE:-98.22%
ROA:-52.33%
PB:3.58
PE(LYR):-3.50

Loading ...

Aug 03, 2020

Major Issues Report

8-K - Current report
Aug 03, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 09, 2020

Major Issues Report

8-K - Current report
Jun 18, 2020

Major Issues Report

8-K - Current report
May 04, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 14, 2020

Major Issues Report

8-K - Current report
Mar 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Dec 27, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 30, 2019

Major Issues Report

Current report, items 2.02, 2.05, 8.01, and 9.01
Sep 25, 2019

Major Issues Report

Current report, items 5.02 and 9.01